Andrew L Feldman

Andrew L Feldman

UNVERIFIED PROFILE

Are you Andrew L Feldman?   Register this Author

Register author
Andrew L Feldman

Andrew L Feldman

Publications by authors named "Andrew L Feldman"

Are you Andrew L Feldman?   Register this Author

100Publications

2275Reads

32Profile Views

Cutaneous lesions of angioimmunoblastic T-cell lymphoma: Clinical, pathological, and immunophenotypic features.

J Cutan Pathol 2019 Sep 3;46(9):637-644. Epub 2019 May 3.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1111/cup.13475
Publisher Site
http://dx.doi.org/10.1111/cup.13475DOI Listing
September 2019

Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.

Expert Rev Hematol 2019 Jul 31:1-11. Epub 2019 Jul 31.

a Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2019.1647777DOI Listing
July 2019

Genetic alterations affecting GTPases and T-cell receptor signaling in peripheral T-cell lymphomas.

Small GTPases 2019 Jan 6;10(1):33-39. Epub 2017 Jan 6.

a Department of Laboratory Medicine and Pathology , Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21541248.2016.1263718DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343532PMC
January 2019

Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts.

J Clin Oncol 2019 Jan 27;37(2):144-152. Epub 2018 Nov 27.

1 Hospices Civils de Lyon, Centre Hospitalier Lyon Sud; Université de Lyon, Université Claude Bernard Lyon 1, Centre de Recherche en Cancérologie de Lyon INSERM 1052, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.18.00400DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366812PMC
January 2019

Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).

Aesthet Surg J 2019 Jan;39(Supplement_1):S14-S20

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/asj/sjy311DOI Listing
January 2019

Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia.

Nat Commun 2018 10 10;9(1):4182. Epub 2018 Oct 10.

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, 20892, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-06541-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180091PMC
October 2018

HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.

Cancer Res 2018 07 7;78(14):4086-4096. Epub 2018 May 7.

Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-17-2900DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065509PMC
July 2018

Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials.

J Clin Oncol 2018 06 19;36(16):1603-1610. Epub 2018 Apr 19.

Matthew J. Maurer, Thomas M. Habermann, Carrie A. Thompson, Cristine Allmer, Patrick B. Johnston, Ivana N. Micallef, David J. Inwards, William R. Macon, Andrew L. Feldman, Susan L. Slager, Stephen M. Ansell, James R. Cerhan, Thomas E. Witzig, and Grzegorz S. Nowakowski, Mayo Clinic, Rochester, MN; Hervé Ghesquières and Gilles A. Salles, Université Claude Bernard, Lyon; Jean-Philippe Jais, Richard Delarue, Thierry J. Molina, Hopital Necker, Paris; Corinne Haioun, Groupe Hospitalier Mondor, Créteil; Frederic Peyrade, Centre Antoine Lacassagne, Nice; Olivier Fitoussi, Polyclinique Bordeaux Nord-Aquitaine, Bordeaux; Hervé Tilly, Centre de lutte Contre le Cancer Henri Becquerel, Rouen, France; Brian K. Link, Umar Farooq, Sergei Syrbu, and George J. Weiner, University of Iowa, Iowa City, IA; and Nicolas Ketterer, Clinique Bois-Cerf, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.5198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978469PMC
June 2018

Ethnic disparity in primary cutaneous CD30 T-cell lymphoproliferative disorders: an analysis of 1496 cases from the US National Cancer database.

Br J Haematol 2018 06 20;181(6):721-722. Epub 2018 Apr 20.

Winship Cancer Institute, Emory University, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.15221
Publisher Site
http://dx.doi.org/10.1111/bjh.15221DOI Listing
June 2018

STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia.

Hum Pathol 2018 03 27;73:74-81. Epub 2017 Dec 27.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2017.12.014DOI Listing
March 2018

SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq).

Cancer Genet 2018 02 2;221:1-18. Epub 2017 Dec 2.

Center for Individualized Medicine-Biomarker Discovery, Mayo Clinic, Rochester MN, USA; Department of Molecular Medicine, Mayo Clinic, Rochester MN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergen.2017.11.009DOI Listing
February 2018

In situ neoplasia in lymph node pathology.

Semin Diagn Pathol 2018 Jan 10;35(1):76-83. Epub 2017 Nov 10.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semdp.2017.11.001DOI Listing
January 2018

International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma.

J Clin Oncol 2017 Dec 26;35(36):4019-4026. Epub 2017 Oct 26.

Matthew J. Maurer, N. Nora Bennani, Stephen M. Ansell, James R. Cerhan, and Andrew L. Feldman, Mayo Clinic, Rochester, MN; Fredrik Ellin, Kalmar County Hospital, Kalmar; Fredrik Ellin and Thomas Relander, Lund University; Mats Jerkeman and Thomas Relander, Skåne University Hospital, Lund; Karin E. Smedby, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; Line Srour, Joseph M. Connors, Graham W. Slack, and Kerry J. Savage, Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, British Columbia, Canada; and Brian K. Link, University of Iowa Hospitals and Clinics, Iowa City, IA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.8195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736237PMC
December 2017

Nodular Lymphocyte Predominant Hodgkin Lymphoma of the Ileum.

Case Rep Pathol 2017 2;2017:5981013. Epub 2017 Nov 2.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
https://www.hindawi.com/journals/cripa/2017/5981013/
Publisher Site
http://dx.doi.org/10.1155/2017/5981013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688355PMC
November 2017

Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma.

JCO Precis Oncol 2017 1;2017. Epub 2017 Aug 1.

David L. Marks, Tara L. Hogenson, Anne M. Vrabel, Ashley N. Sigafoos, Ezequiel J. Tolosa, Ryan M. Carr, Stephanie L. Safgren, Elisa Enriquez Hesles, Luciana L. Almada, Paola A. Romecin-Duran, Eriko Iguchi, Aryan Ala'Aldeen, Jean-Pierre A. Kocher, Gavin R. Oliver, Naresh Prodduturi, David W. Mead, Asif Hossain, Norine E. Huneke, Colleen M. Tagtow, Sikander Ailawadhi, Stephen M. Ansell, Michaela S. Banck, Asher A. Chanan-Khan, Ronald S. Go, Thorvardur R. Halfdanarson, Richard W. Joseph, Prashant Kapoor, Aaron S. Mansfield, Amulya A. Nageswara Rao, Grzegorz S. Nowakowski, Animesh Pardanani, Sameer A. Parikh, John C. Cheville, Andrew L. Feldman, Ramesh K. Ramanathan, Steven I. Robinson, Heidi D. Finnes, Jennifer B. McCormick, Robert R. McWilliams, Aminah Jatoi, Mrinal M. Patnaik, Eric D. Wieben, Tammy M. McAllister, Kandelaria M. Rumilla, Sarah E. Kerr, Konstantinos N. Lazaridis, Gianrico Farrugia, Karl J. Clark, Eric W. Klee, and Martin E. Fernandez-Zapico, Mayo Clinic, Rochester; Ernesto Resnik, Bio-Techne, Minneapolis, MN; Sikander Ailawadhi, Asher A. Chanan-Khan, and Richard W. Joseph, Mayo Clinic, Jacksonville, FL; Jan B. Egan, Alan H. Bryce, Estrella M. Carballido, KellyK. Curtis, Chelsea D. Gawryletz, Thai H. Ho,Nathalie Meurice, Ramesh K. Ramanathan, Raoul Tibes, Alvin C. Silva, A. Keith Stewart, and Mitesh J. Borad, Mayo Clinic, Phoenix, AZ; and Eileen J. Kennedy, University of Georgia, Athens, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.17.00018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369924PMC
August 2017

Lymphoma classification update: B-cell non-Hodgkin lymphomas.

Expert Rev Hematol 2017 05 24;10(5):405-415. Epub 2017 Apr 24.

a Department of Laboratory Medicine and Pathology , Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17474086.2017.1
Publisher Site
http://dx.doi.org/10.1080/17474086.2017.1318053DOI Listing
May 2017

Genetic Landscape and Classification of Peripheral T Cell Lymphomas.

Curr Oncol Rep 2017 Apr;19(4):28

Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-017-0582-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517131PMC
April 2017

Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.

Expert Rev Hematol 2017 Mar 29;10(3):239-249. Epub 2017 Jan 29.

a Department of Laboratory Medicine and Pathology , Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17474086.2017.1
Publisher Site
http://dx.doi.org/10.1080/17474086.2017.1281122DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514564PMC
March 2017

Adult systemic anaplastic large-cell lymphoma: recommendations for diagnosis and management.

Expert Rev Hematol 2016 11;9(2):137-50. Epub 2015 Dec 11.

b Department of Laboratory Medicine and Pathology , Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2016.1122514DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876810PMC
November 2016

Genetics of anaplastic large cell lymphoma.

Leuk Lymphoma 2016 21;57(1):21-7. Epub 2015 Jul 21.

a Department of Laboratory Medicine and Pathology , Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1064530DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732699PMC
October 2016

Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al.

Haematologica 2016 06 31;101(6):e269-70. Epub 2016 May 31.

Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2016.147074DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013938PMC
June 2016

Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma.

Biomark Med 2015 30;9(8):719-22. Epub 2015 Jul 30.

Department of Laboratory Medicine & Pathology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/BMM.15.37DOI Listing
May 2016

UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma.

Blood 2016 Mar 23;127(12):1564-74. Epub 2015 Dec 23.

Department of Pediatric and Adolescent Medicine, Division of Pediatric Hematology-Oncology, and Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-07-656678DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807423PMC
March 2016

Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.

Am J Surg Pathol 2016 Jan;40(1):36-43

*Department of Laboratory Medicine and Pathology ††Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN †Hematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, MD ‡Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles, CA §Division of Hematopathology, University of Pittsburgh Medical Center, Pittsburgh, PA ∥Department of Pathology and Laboratory Medicine, United Health Services Hospitals, Johnson City/Binghamton #Department of Pathology and Laboratory Medicine, Centrex Clinical Laboratories, Utica, NY ¶Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH **Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL ‡‡Department of Pathology, Duke University, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000500DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834837PMC
January 2016

Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.

J Clin Oncol 2015 Nov 12;33(33):3930-7. Epub 2015 Oct 12.

Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.2573DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879713PMC
November 2015

Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma.

Appl Immunohistochem Mol Morphol 2015 Sep;23(8):580-9

*Department of Laboratory Medicine and Pathology ∥Division of Hematology, Mayo Clinic, Rochester, MN †Department of Pathology, Affiliated Hospital of Medical College, Qingdao University, Qingdao, China ‡Department of Hematology-Oncology, National University Cancer Institute of Singapore §Cancer Science Institute of Singapore, National University Cancer Institute of Singapore, Singapore, Singapore ¶Department of Pathology and Laboratory Medicine, United Health Services Hospitals, Johnson City/Binghamton, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427553PMC
September 2015

Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.

Adv Anat Pathol 2015 Jan;22(1):29-49

*Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN †Department of Pathology, Affiliated Hospital of Medical College, Qingdao University, Qingdao, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0000000000000047DOI Listing
January 2015

RVboost: RNA-seq variants prioritization using a boosting method.

Bioinformatics 2014 Dec 27;30(23):3414-6. Epub 2014 Aug 27.

Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street SW, Rochester MN 55905, Department of Health Sciences Research, Mayo Clinic, 4500 San Pablo Road South, Jacksonville FL 32224, Department of Laboratory Medicine and Pathology, Division of Hematology, Department of Internal Medicine, Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester MN 55905 and Department of Cancer Biology, Mayo Clinic, 4500 San Pablo Road South, Jacksonville FL 32224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btu577DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296157PMC
December 2014

Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.

Am J Surg Pathol 2014 Sep;38(9):1203-11

Departments of *Pathology #Dermatology, Stanford University School of Medicine, Stanford †UCLA Medical Center, Los Angeles ‡San Diego Pathologists Medical Group, San Diego, CA §Department of Dermatology, Mayo Clinic, Jacksonville, FL ∥Department of Pathology, Massachusetts General Hospital, Boston, MA ¶Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ajsp/2014/09000/Intralymphatic_
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PAS.0000000000000217DOI Listing
September 2014

Medical history, lifestyle, family history, and occupational risk factors for peripheral T-cell lymphomas: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

J Natl Cancer Inst Monogr 2014 Aug;2014(48):66-75

Department of Cancer Etiology, Beckman Research Institute of the City of Hope, Duarte, CA (SSW); Winship Cancer Institute, Emory University, Atlanta, GA (CRF); Department of Dermatology, Boston University, Boston, MA, Roger Williams Medical Center, Providence, RI (MEK); Health Sciences Practice, Exponent, Inc., Menlo Park, CA, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA (ETC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SMA); Department of Laboratory Medicine and Pathology, Mayo Clinic Cancer Center, Rochester, MN (ALF); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK (TL); Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY (PB); Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark (MM); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (QL, JNS, LMM); Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT (YZ); Department of Pathology, City of Hope National Medical Center, Duarte, CA (DDW).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgu012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155466PMC
August 2014

Medical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and Sézary syndrome: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

J Natl Cancer Inst Monogr 2014 Aug;2014(48):98-105

Department of Health Studies, University of Chicago, Chicago, IL (BA-K); Department of Public Health, Clinical and Molecular Medicine, Occupational Health Section, University of Cagliari, Cagliari, Italy (PC); Dipartimento di Epidimologia, IRCCS- Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy, Community Health, University of Milan, Milan, Italy (CLV); Health Sciences Practice, Exponent, Inc., Menlo Park, CA, Department of Health Research and Policy, Stanford University, Stanford, CA (ETC); Prince of Wales Clinical School, University of New South Wales, Sydney, Australia (CMV); Department of Dermatology, Boston University, Boston, MA, Roger Williams Medical Center, Providence, RI (MEK); Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada, School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada (JJS); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health Bethesda, MD (LMM, JNS); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK (EVK); Biostatistics Center, Massachusetts General Hospital, Boston, MA (CK); Department of Laboratory Medicine and Pathology, Mayo Clinic Cancer Center, Rochester, MN (ALF); Division of Cancer Etiology, Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA (SSW); Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT (YZ).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgu008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155463PMC
August 2014

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

J Natl Cancer Inst Monogr 2014 Aug;2014(48):130-44

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (LMM, SMM, JSC, PH, NR, AB, KPC, QL, SIB, MSL, JNS); Department of Health Sciences Research (SLS, JRC, TMH), Division of Hematology (TGC), and Divison of General Internal Medicine (ML), College of Medicine, Mayo Clinic, Rochester, MN; Department of Cancer Etiology, City of Hope Beckman Research Institute, Duarte, CA (SSW, LB, AL); Prince of Wales Clinical School, University of New South Wales, Sydney, Australia (CMV); Department of Epidemiology, Comprehensive Cancer Center, University of Alabama, Birmingham, AL (CFS); Department of Epidemiology and Biostatistics, School of Medicine, University of California San Francisco, San Francisco, CA (PMB, EAH); Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Institut Català d' Oncologia, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain, CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain (SdS, YB); Unit of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden (KES); Department of Health Studies, University of Chicago, Chicago, IL (BCHC); Department of Environmental Health Sciences (YZ, TZ) and Department of Biostatistics (TRH), Yale School of Public Health, New Haven, CT; INSERM, Centre for Research in Epidemiology and Population Health (CESP), U1018, Environmental Epidemiology of Cancer Group, Villejuif, France, Univ Paris Sud, UMRS 1018, Villejuif, France (AM, JC, LO); Registry of Hematological Malignancies in Gironde, Bergonié Institute, 33076 Bordeaux, France (AM); Department of Histopathology, Douglass Hanly Moir Pathology, Macquarie Park, Australia, The Australian School of Advanced Medicine, Macquarie University, Sydney, Australia (JJT); Department of Medical Epidemiology and Biostatistics (H-OA) and Department of Oncology and Pathology (BG), Karolinska Institutet, Stockholm, Swed

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgu013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155467PMC
August 2014

Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma.

Clin Cancer Res 2014 Jun 11;20(11):2862-72. Epub 2014 Apr 11.

Authors' Affiliations: Division of Hematology; Division of Epidemiology; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; and Department of Hematology, Tongji Hospital, Tongji University, Shanghai, China

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2367DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058762PMC
June 2014

Clonal Relationships Between Malignant Lymphomas and Histiocytic/Dendritic Cell Tumors.

Authors:
Andrew L Feldman

Surg Pathol Clin 2013 Dec 19;6(4):619-29. Epub 2013 Sep 19.

Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18759181130008
Publisher Site
http://dx.doi.org/10.1016/j.path.2013.08.003DOI Listing
December 2013

Novel TRAF1-ALK fusion identified by deep RNA sequencing of anaplastic large cell lymphoma.

Genes Chromosomes Cancer 2013 Nov 2;52(11):1097-102. Epub 2013 Sep 2.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22104DOI Listing
November 2013

Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.

JAMA Ophthalmol 2013 Sep;131(9):1151-8

Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota2Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaophthalmol.2013.334DOI Listing
September 2013

ITK/SYK translocation in angioimmunoblastic T-cell lymphoma.

Am J Surg Pathol 2013 Sep;37(9):1456-7

*Department of Histopathology, Royal Marsden Hospital, London, UK †Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ajsp/2013/09000/ITK_SYK_Translo
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PAS.0b013e3182991415DOI Listing
September 2013

Ubiquitin hydrolase UCH-L1 destabilizes mTOR complex 1 by antagonizing DDB1-CUL4-mediated ubiquitination of raptor.

Mol Cell Biol 2013 Mar 7;33(6):1188-97. Epub 2013 Jan 7.

Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/MCB.01389-12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3592026PMC
March 2013

Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases.

J Cutan Pathol 2013 Feb 28;40(2):236-47. Epub 2012 Nov 28.

Department of Dermatopathology, The Medical College of Wisconsin, Milwaukee, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cup.12047DOI Listing
February 2013

Mate pair sequencing of whole-genome-amplified DNA following laser capture microdissection of prostate cancer.

DNA Res 2012 Oct 18;19(5):395-406. Epub 2012 Sep 18.

Department of Molecular Medicine, Mayo Clinic, Medical Sciences Building 2, 200 First St., SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/dnares/dss021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3473372PMC
October 2012

Clinicopathologic features of B-Cell lineage neoplasms with aberrant expression of CD3: a study of 21 cases.

Am J Surg Pathol 2012 Sep;36(9):1364-70

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PAS.0b013e31825e63a9DOI Listing
September 2012

Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases.

Mod Pathol 2011 Nov 10;24(11):1421-32. Epub 2011 Jun 10.

Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2011.102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175277PMC
November 2011

CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus.

Cancer Genet 2011 Mar;204(3):162-4

Department of Pathology, Baylor University Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2010.08.016DOI Listing
March 2011